Androgen ablation augments human HLA2.1‐restricted T cell responses to PSA self‐antigen in transgenic mice

Abstract

This humanized hybrid mouse model provides a well-defined system to gain additional insight into the mechanisms of immune tolerance to PSA and to test novel strategies aiming at circumventing immune tolerance to PSA and other TAA for targeted prostate cancer immunotherapy.

References

Page 1

	Year	Citations
Prostate cancer in a transgenic mouse. Norman M. Greenberg, Francesco J. DeMayo, Milton J. Finegold, Proceedings of the National Academy of Sciences Lineage PlasticityUrologyDevelopmental BiologyTransgenic Mouse ModelsGenitourinary Cancer	1995	1.3K
Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer Eric J. Small, Paul F. Schellhammer, Celestia S. Higano, Journal of Clinical Oncology	2006	1.1K
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer Philip W. Kantoff, Thomas Schuetz, Brent A. Blumenstein, Journal of Clinical Oncology	2010	969
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer Scott A. Tomlins, Bharathi Laxman, Sooryanarayana Varambally, Neoplasia Prostatic DiseaseCancer GeneticsTmprss2-erg Gene FusionMedicineRadiation Oncology	2008	691
Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance Jeff M. Holzbeierlein, Priti Lal, Éva Latulippe, American Journal Of Pathology Radiation OncologyEndocrine-related CancerMedicineCancer GenomicsHuman Prostate Carcinoma	2004	571
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors Axel Heiser, Doris Coleman, Jens Dannull, Journal of Clinical Investigation	2002	489
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. Jonathan W. Simons, Bahar Mikhak, Ju-Fay Chang, PubMed VaccinationTumor ImmunologyCancer ImmunosurveillanceCancer AntigensImmunology	1999	468
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors Axel Heiser, Doris Coleman, Jens Dannull, Journal of Clinical Investigation ImmunologyImmune RegulationCd4 T Cell ResponsesImmunotherapeuticsAutologous Dendritic Cells	2002	442
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer Eugene D. Kwon, Arthur A. Hurwitz, Barbara A. Foster, Proceedings of the National Academy of Sciences	1997	391
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer Maria Mercader, Barbara Bodner, Micheal T. Moser, Proceedings of the National Academy of Sciences	2001	383

Page 1